Skip to content

FLANDERS.BIO

Inactive
KBO/BCE: BE 0863.763.620

Inactive; last annual accounts for financial year 2024. Dissolved without liquidation.

FLANDERS.BIOInactive

Overview

Activity
Activity not known
Size
€898,016turnover 2024
Staff
5.6 FTE
Equity
€825,712
Loss
-€355,692
Financial health
Inactive: no score
Structure
Board
7 members
  • VibioDaily manager · permanent representative Patrik De Haes
3 of 23 deeds read
Signalsraises riskAnnual accounts not filedneutralLatest accounts filed on timeShow the evidence

Signals

Two signals.
raises riskneutral
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 79 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline18-10-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 10-06-2025, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
51 days early
2023
13 days early
2022
67 days early
2021
19 days early
2020
23 days early
2019
15 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 6 accounts on average 31 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · abbreviated…
  2. Restructuring · End & cessationMerger · Auditor report ·…
  3. Resignation: Wouter Piepers (day-to-day manager)Appointments: Vibio, Montis Biosciences and…

Key points

  • Risk: No longer active Inactive View
  • Caution: From profit to loss in 2024after €13,149 in 2023 -€355,692 View
  • Flemish supportawarded from 2022 to 2024 €180,000 View

By topic

Financials

Financial year
2024
Turnover
€898,016
Loss
-€355,692
Solvency
70.8%
Turnover▼ 16.0%
Net result
20232024
Go to Financials

Board & ownership

Board
7 members
  • 2 Bridge NVDirector
  • Montis BiosciencesDirector
  • NV PMVDirector
  • QbD Flanders NVDirector
  • BIOQUBE VENTURES NVDirector

and 2 other directors

Go to Board & ownership

Timeline

Events
28
Since
2006
  1. 31-12-2024Weakest financial year
  2. 24-07-2024Permanent representatives: Marieke Vermeersch and Erik Present
  3. 18-07-2024Annual accounts filed
Go to Timeline

Go further with this company

Investigating this company? Keep it with today's facts in a case file.